Aerosol delivery and humidification with the boussignac continuous positive airway pressure device

Respiratory Care

Volumn 56, Issue 10, 2011, Pages 1526-1532

  Thille, Arnaud W ^a   Bertholon, Jean François ^b   Becquemin, Marie Hélène ^c   Roy, Monique ^c   Lyazidi, Aissam ^a   Lellouche, François ^a   Pertusini, Esther ^a   Boussignac, Georges ^a   Maître, Bernard ^a   Brochard, Laurent ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

2 agonist; Aerosol therapy; Bronchodilator; Continuous positive airway pressure; CPAP; Heat and moisture exchanger; Heated humidifier; Work of breathing

Indexed keywords

TERBUTALINE;

ACUTE RESPIRATORY FAILURE; ADULT; AEROSOL; AIRWAY OBSTRUCTION; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FACE MASK; FEMALE; HUMAN; HUMIDIFIER; HUMIDITY; LUNG ALVEOLUS OXYGEN TENSION; LUNG PRESSURE; MALE; NEBULIZATION; PARTICLE SIZE; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY AIRFLOW;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AEROSOLS; BRONCHIAL DISEASES; BRONCHODILATOR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HUMIDITY; PARTICLE SIZE; PULMONARY GAS EXCHANGE; TERBUTALINE; WORK OF BREATHING;

EID: 82455167152     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00847     Document Type: Article

References (40)

1. Bersten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 1991;325(26):1825-1830.
2. Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA 2005;294(24):3124-3130.
3. Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, et al. Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA 2005; 293(5):589-595.
4. Appendini L, Patessio A, Zanaboni S, Carone M, Gukov B, Donner CF, et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;149(5):1069-1076.
5. O'Donoghue FJ, Catcheside PG, Jordan AS, Bersten AD, McEvoy RD. Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD. Thorax 2002;57(6):533-539.
6. Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988; 65(4):1488-1499.
7. Petrof BJ, Legare M, Goldberg P, Milic-Emili J, Gottfried SB. Continuous positive airway pressure reduces work of breathing and dyspnea during weaning from mechanical ventilation in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141(2):281-289.
8. Mancebo J, Albaladejo P, Touchard D, Bak E, Subirana M, Lemaire F, et al. Airway occlusion pressure to titrate positive end-expiratory pressure in patients with dynamic hyperinflation. Anesthesiology 2000;93(1):81-90.
9. Moritz F, Brousse B, Gellee B, Chajara A, L'Her E, Hellot MF, et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Ann Emerg Med 2007;50(6):666-675, e661.
10. O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;1(8652):1418-1420.
11. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000;161(6):1862-1868.
12. Clay MM, Pavia D, Newman SP, Lennard-Jones T, Clarke SW. Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983; 2(8350):592-594.
13. Newman KB, Milne S, Hamilton C, Hall K. A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. Chest 2002;121(4):1036-1041.
14. Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, et al. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med 1994;149(6):1466-1470.
15. Frischknecht-Christensen E, Norregaard O, Dahl R. Treatment of bronchial asthma with terbutaline inhaled by conespacer combined with positive expiratory pressure mask. Chest 1991;100(2):317-321.
16. Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997;52(2):171-175.
17. Pollack CV Jr, Fleisch KB, Dowsey K. Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med 1995;26(5): 552-557.
18. Fauroux B, Itti E, Pigeot J, Isabey D, Meignan M, Ferry G, et al. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med 2000;162(6):2265-2271.
19. Nava S, Karakurt S, Rampulla C, Braschi A, Fanfulla F. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study. Intensive Care Med 2001;27(10):1627-1635.
20. Chatmongkolchart S, Schettino GP, Dillman C, Kacmarek RM, Hess DR. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med 2002;30(11):2515-2519.
21. Ricard JD, Le Miere E, Markowicz P, Lasry S, Saumon G, Djedaini K, et al. Efficiency and safety of mechanical ventilation with a heat and moisture exchanger changed only once a week. Am J Respir Crit Care Med 2000;161(1):104-109.
22. Derom E, Borgstrom L, Van Schoor J, Lofroos AB, Pauwels R. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals. Am J Respir Crit Care Med 2001;164(8 Pt 1):1398-1402.
23. Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J. A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis 1982;126(5):788-791.
24. Sassoon CS, Light RW, Lodia R, Sieck GC, Mahutte CK. Pressuretime product during continuous positive airway pressure, pressure support ventilation, and T-piece during weaning from mechanical ventilation. Am Rev Respir Dis 1991;143(3):469-475.
25. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis 1982;126(1):166-170.
26. Lessard MR, Lofaso F, Brochard L. Expiratory muscle activity increases intrinsic positive end-expiratory pressure independently of dynamic hyperinflation in mechanically ventilated patients. Am J Respir Crit Care Med 1995;151(2 Pt 1):562-569.
27. Clay MM, Pavia D, Newman SP, Clarke SW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983;38(10): 755-759.
28. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154(1):182-186.
29. Lellouche F, Maggiore SM, Lyazidi A, Deye N, Taille S, Brochard L. Water content of delivered gases during non-invasive ventilation in healthy subjects. Intensive Care Med 2009;35(6):987-995.
30. Chanques G, Constantin JM, Sauter M, Jung B, Sebbane M, Verzilli D, et al. Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients. Intensive Care Med 2009; 35(6):996-1003.
31. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 2003;168(10):1205-1209.
32. Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care;55(7):837-844.
33. Man WD, Mustfa N, Nikoletou D, Kaul S, Hart N, Rafferty GF, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004;59(6):471-476.
34. Mancebo J, Amaro P, Lorino H, Lemaire F, Harf A, Brochard L. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 1991;144(1): 95-100.
35. Ranieri VM, Giuliani R, Cinnella G, Pesce C, Brienza N, Ippolito EL, et al. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis 1993;147(1):5-13.
36. Franca EE, Dornelas de Andrade AF, Cabral G, Almeida Filho P, Silva KC, Galindo Filho VC, et al. Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition. Respir Med 2006;100(4):721-728.
37. Reychler G, Keyeux A, Cremers C, Veriter C, Rodenstein DO, Liistro G. Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization. Chest 2004; 125(2):502-508.
38. Reychler G, Leal T, Roeseler J, Thys F, Delvau N, Liistro G. Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin. Respir Med 2007;101(10):2051-2055.
39. Dolovich MB, Killian D, Wolff RK, Obminski G, Newhouse MT. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis 1977;115(3):397-402.
40. Laube BL, Geller DE, Lin TC, Dalby RN, Diener-West M, Zeitlin PL. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis. Respir Care 2005;50(11):1438-1444.